UnitedHealth Group (UNH) Stock Forecast & Price Target

The positive outlook for UnitedHealth Group's stock is underpinned by strong projected earnings growth, with overall earnings expected to rise by 13% in 2026, primarily fueled by margin improvements in the Medicare and commercial segments. The diversified Optum franchises contribute significantly to this growth, with Optum Health earnings anticipated to increase by approximately 9%, while Optum Rx and Optum Insight also show promising growth trajectories, supported by expanding margins across the various business segments. Additionally, UnitedHealth's vertical integration strategy enhances its competitive positioning and complements its core managed care operations, further solidifying its robust standing in the healthcare sector.

UnitedHealth Group is projected to face a substantial decline in membership, with estimates indicating a reduction of 1.3 to 1.4 million members for the year 2026, primarily driven by losses in the Marketplace and higher-than-expected plan shopping in the Medicare Advantage segment. Additionally, the company's Medicaid margins are anticipated to decrease significantly from 0.1% in 2025 to -1.8% in 2026 due to the adverse impacts of new Medicaid work requirements, alongside a loss of approximately 300,000 lives. Furthermore, the recent proposal from CMS for FY2027 MA rates has underwhelmed expectations, suggesting minimal rate increases that fall short of offsetting inflation and elevated utilization trends, which could further challenge UnitedHealth’s financial performance.